Wird geladen...
A163 DIRECT ACTING ANTIVIRAL UPTAKE DISPARITIES IN HIV-HEPATITIS C CO-INFECTED POPULATIONS IN CANADA
BACKGROUND: Direct acting antivirals (DAAs) have revolutionized hepatitis C (HCV) treatment with nearly 100% cure rates even in real-world studies, giving hope that HCV can be eliminated. Historically, HCV treatment initiation rates have been low, particularly among people who inject drugs (PWID) an...
Gespeichert in:
| Veröffentlicht in: | J Can Assoc Gastroenterol |
|---|---|
| Hauptverfasser: | , , , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Oxford University Press
2018
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6507735/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jcag/gwy008.164 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|